Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 2
2016 2
2017 1
2018 1
2019 2
2020 4
2022 1
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
A comparison of outcomes for patients with intermediate and high risk prostate cancer treated with low dose rate and high dose rate brachytherapy in combination with external beam radiotherapy.
Slevin F, Rodda SL, Bownes P, Murray L, Bottomley D, Wilkinson C, Adiotomre E, Al-Qaisieh B, Dugdale E, Hulson O, Mason J, Smith J, Henry AM. Slevin F, et al. Among authors: adiotomre e. Clin Transl Radiat Oncol. 2019 Oct 14;20:1-8. doi: 10.1016/j.ctro.2019.10.001. eCollection 2020 Jan. Clin Transl Radiat Oncol. 2019. PMID: 31701035 Free PMC article.
Response to 'Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer'.
Slevin F, Rodda SL, Bownes P, Murray L, Bottomley D, Melody C, Adiotomre E, Al-Qaisieh B, Dugdale E, Hulson O, Mason J, Smith J, Henry AM. Slevin F, et al. Among authors: adiotomre e. Clin Transl Radiat Oncol. 2020 Jun 10;24:52. doi: 10.1016/j.ctro.2020.06.001. eCollection 2020 Sep. Clin Transl Radiat Oncol. 2020. PMID: 32637660 Free PMC article. No abstract available.
Efficacy and toxicity outcomes for patients treated with focal salvage high dose rate brachytherapy for locally recurrent prostate cancer.
Slevin F, Hodgson S, Rodda SL, Bownes P, Bottomley D, Adiotomre E, Al-Qaisieh B, Dugdale E, Hulson O, Mason J, Smith J, Henry AM. Slevin F, et al. Among authors: adiotomre e. Clin Transl Radiat Oncol. 2020 Mar 27;23:20-26. doi: 10.1016/j.ctro.2020.03.010. eCollection 2020 Jul. Clin Transl Radiat Oncol. 2020. PMID: 32368626 Free PMC article.
13 results